share_log

Nxu Inc | 10-Q: Q3 2024 Earnings Report

Nxu Inc | 10-Q: Q3 2024 Earnings Report

Nxu Inc | 10-Q：2024财年三季报
美股SEC公告 ·  2024/11/14 00:38

Moomoo AI 已提取核心信息

Nxu Inc. reported Q3 2024 financial results with revenue of $6,000 and a net loss of $5 million, compared to a net loss of $10.4 million in Q3 2023. Operating expenses decreased significantly to $3.1 million from $11.3 million year-over-year, primarily due to reduced research and development costs and lower general administrative expenses.The company ended the quarter with $2.2 million in cash and announced a definitive merger agreement with Verde Bioresins on October 23, 2024. Under the agreement, Verde shareholders will own approximately 95% of the combined company while Nxu shareholders will retain about 5%. The merger is expected to close by March 31, 2025, subject to shareholder and regulatory approvals.Management continues to implement cost-saving measures including headcount reductions and asset sales. The company raised $10.7 million through ATM offerings during the first nine months of 2024 but noted substantial doubt about its ability to continue as a going concern without additional funding. The merger with Verde is viewed as a strategic alternative to enhance shareholder value.
Nxu Inc. reported Q3 2024 financial results with revenue of $6,000 and a net loss of $5 million, compared to a net loss of $10.4 million in Q3 2023. Operating expenses decreased significantly to $3.1 million from $11.3 million year-over-year, primarily due to reduced research and development costs and lower general administrative expenses.The company ended the quarter with $2.2 million in cash and announced a definitive merger agreement with Verde Bioresins on October 23, 2024. Under the agreement, Verde shareholders will own approximately 95% of the combined company while Nxu shareholders will retain about 5%. The merger is expected to close by March 31, 2025, subject to shareholder and regulatory approvals.Management continues to implement cost-saving measures including headcount reductions and asset sales. The company raised $10.7 million through ATM offerings during the first nine months of 2024 but noted substantial doubt about its ability to continue as a going concern without additional funding. The merger with Verde is viewed as a strategic alternative to enhance shareholder value.
Nxu Inc. 报告了2024年第三季度的财务结果，营业收入为6,000美元，净亏损为500万，与2023年第三季度的净亏损1,040万相比有所改善。营业费用从上年的1,130万显著减少至310万，主要是由于研发成本的降低和一般管理费用的减少。公司在季度末现金余额为220万，并于2024年10月23日宣布与Verde Bioresins达成最终合并协议。根据协议，Verde股东将拥有合并公司约95%的股份，而Nxu股东将保留约5%的股份。预计合并将于2025年3月31日前完成，需经过股东和监管机构的批准。管理层继续实施成本节约措施，包括裁员和资产出售。公司在2024年前九个月通过ATm发行筹集了1,070万，但表示在没有额外资金的情况下继续作为持续经营的公司存在重大疑虑。与Verde的合并被视为增强股东价值的战略替代方案。
Nxu Inc. 报告了2024年第三季度的财务结果，营业收入为6,000美元，净亏损为500万，与2023年第三季度的净亏损1,040万相比有所改善。营业费用从上年的1,130万显著减少至310万，主要是由于研发成本的降低和一般管理费用的减少。公司在季度末现金余额为220万，并于2024年10月23日宣布与Verde Bioresins达成最终合并协议。根据协议，Verde股东将拥有合并公司约95%的股份，而Nxu股东将保留约5%的股份。预计合并将于2025年3月31日前完成，需经过股东和监管机构的批准。管理层继续实施成本节约措施，包括裁员和资产出售。公司在2024年前九个月通过ATm发行筹集了1,070万，但表示在没有额外资金的情况下继续作为持续经营的公司存在重大疑虑。与Verde的合并被视为增强股东价值的战略替代方案。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Amprius Technologies
    AMPX
    -- 2.770
    Lightbridge
    LTBR
    -- 9.860
    CCSC Technology International
    CCTG
    -- 1.760
    Vertiv Holdings
    VRT
    -- 98.610
    普拉格能源
    PLUG
    -- 1.680
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    中概股集体大涨！2025年中国资产前景如何？
    近期，Goldman Sachs、Morgan Stanley、Appaloosa LP等多家机构唱好中国资产。 $阿里巴巴 (BABA.US)$ 、 $京东 (JD.US)$ 、 $富途控股 (FUTU.US)$ 等中概股价格飙升，市场情绪火热。 🎙️讨论： Deepseek 展开
    中国股票的疯狂反弹暂停？华尔街仍在大举押注热门股票